Analysts Set M.D.C. Holdings, Inc. (NYSE:MDC) Target Price at $52.13

M.D.C. Holdings, Inc. (NYSE:MDC) has been given a consensus rating of “Reduce” by the five ratings firms that are covering the company, Marketbeat Ratings reports. One analyst has rated the stock with a sell rating and four have given a hold rating to the company. The average 1 year price target among brokers that have issued ratings on the stock in the last year is $52.13.

A number of research analysts recently issued reports on the stock. Evercore ISI downgraded shares of M.D.C. from an “outperform” rating to an “in-line” rating and boosted their target price for the company from $57.00 to $63.00 in a research report on Wednesday, January 31st. Raymond James reiterated a “market perform” rating on shares of M.D.C. in a report on Wednesday, February 7th. Finally, StockNews.com assumed coverage on M.D.C. in a research note on Sunday. They issued a “hold” rating for the company.

M.D.C. Stock Performance

Shares of MDC stock opened at $62.98 on Friday. The company has a market cap of $4.73 billion, a P/E ratio of 11.93 and a beta of 1.54. M.D.C. has a fifty-two week low of $36.47 and a fifty-two week high of $63.00. The stock has a 50 day simple moving average of $62.87 and a two-hundred day simple moving average of $56.10. The company has a debt-to-equity ratio of 0.50, a quick ratio of 3.92 and a current ratio of 9.76.

Insiders Place Their Bets

In other news, Director David E. Blackford sold 6,200 shares of M.D.C. stock in a transaction dated Monday, March 11th. The shares were sold at an average price of $62.69, for a total transaction of $388,678.00. Following the completion of the transaction, the director now directly owns 13,534 shares in the company, valued at $848,446.46. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Corporate insiders own 23.30% of the company’s stock.

Institutional Investors Weigh In On M.D.C.

Several institutional investors have recently bought and sold shares of the stock. Assenagon Asset Management S.A. purchased a new position in M.D.C. during the 4th quarter worth $2,232,000. WealthPLAN Partners LLC purchased a new position in M.D.C. during the fourth quarter worth about $992,000. Raymond James & Associates grew its position in M.D.C. by 23.0% in the 4th quarter. Raymond James & Associates now owns 898,855 shares of the construction company’s stock worth $49,662,000 after purchasing an additional 168,214 shares in the last quarter. Cornercap Investment Counsel Inc. purchased a new stake in M.D.C. in the 4th quarter valued at about $1,300,000. Finally, Tudor Investment Corp Et Al lifted its position in shares of M.D.C. by 0.8% during the 3rd quarter. Tudor Investment Corp Et Al now owns 117,754 shares of the construction company’s stock worth $4,855,000 after buying an additional 977 shares in the last quarter. Institutional investors own 88.08% of the company’s stock.

M.D.C. Company Profile

M.DC Holdings, Inc, through its subsidiaries, engages in the homebuilding and financial service businesses. Its homebuilding operations include purchasing finished lots or developing lots for the construction and sale primarily of single-family detached homes to first-time and first-time move-up homebuyers under the Richmond American Homes name.